Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Genworth CEO gets $12 million

X
Your article was successfully shared with the contacts you provided.

(Bloomberg) — Genworth Financial Inc. (NYSE:GNW), the biggest seller of private long-term care insurance (LTCI), paid Chief Executive Officer Tom McInerney $12 million for his first year on the job.

The insurer’s stock doubled during that period.

McInerney’s package included a $3 million bonus, $7.06 million in stock options, and a salary of almost $1 million, the insurer said today in a regulatory filing.

Profit has been recovering at Genworth as the insurer raises prices for LTCI policies and a recovery in home values bolsters the mortgage-insurance unit. McInerney, 57, started on Jan. 1, 2013, and announced 400 job cuts in June. The company said the cuts could save it as much as $90 million annually.

“We expect the company to generate strong earnings growth and return on equity expansion over the next few years,” Suneet Kamath, an analyst at UBS AG, said in a March 19 research note. Genworth “is positioned to begin returning capital to shareholders in the year ahead.”

McInerney, a former ING Groep N.V. executive, joined Genworth from Boston Consulting Group, where he served as an adviser. Genworth said McInerney’s target bonus was $2 million when the firm hired him.

He replaced Michael Fraizer, who left on May 1, 2012, after overseeing a share decline of more than 80 percent since 2006. Fraizer got a $2.25 million payment after he resigned from the insurer.

–With assistance from Noah Buhayar in New York.

See also:


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.